{{Rsnum
|rsid=8014194
|Gene=CLMN
|Chromosome=14
|position=95254341
|Orientation=plus
|GMAF=0.2695
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=CLMN
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 1.8 | 36.0 | 62.2
| HCB | 2.2 | 26.3 | 71.5
| JPT | 0.9 | 17.0 | 82.1
| YRI | 34.0 | 45.6 | 20.4
| ASW | 35.1 | 40.4 | 24.6
| CHB | 2.2 | 26.3 | 71.5
| CHD | 1.9 | 24.1 | 74.1
| GIH | 9.1 | 35.4 | 55.6
| LWK | 22.0 | 52.3 | 25.7
| MEX | 8.8 | 31.6 | 59.6
| MKK | 29.5 | 44.2 | 26.3
| TSI | 3.0 | 39.6 | 57.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20339536
|Trait=Response to statin therapy
|Title=Genome-wide association of lipid-lowering response to statins in combined study populations
|RiskAllele=A
|Pval=2E-8
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}